Connect with us

Technology

Laboratory Automation Systems Market size is set to grow by USD 2.01 billion from 2024-2028, Increasing demand for laboratory automation software services boost the market, Technavio

Published

on

NEW YORK, July 31, 2024 /PRNewswire/ — The global laboratory automation systems market size is estimated to grow by USD 2.01 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 8.68%  during the forecast period. Increasing demand for laboratory automation software services is driving market growth, with a trend towards rising number of FDA-approved manufacturing facilities in developing nations. However, lack of adoption of automated solutions by small-scale and medium-scale laboratories  poses a challenge. Key market players include Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Co., Bee Robotics Ltd., Biosero Inc., Cognex Corp., Eppendorf SE, F. Hoffmann La Roche Ltd., Gilson Inc., LabVantage Solutions Inc., LabWare Inc., Olympus Corp., PerkinElmer Inc, QIAGEN NV, SCINOMIX, Siemens AG, SPT Labtech Ltd., Tecan Trading AG, and Thermo Fisher Scientific Inc..

Get a detailed analysis on regions, market segments, customer landscape, and companies- View the snapshot of this report

Laboratory Automation Systems Market Scope

Report Coverage

Details

Base year

2023

Historic period

2018 – 2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 8.68%

Market growth 2024-2028

USD 2.01 billion

Market structure

Fragmented

YoY growth 2022-2023 (%)

8.26

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 42%

Key countries

US, Germany, UK, China, and Japan

Key companies profiled

Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Co., Bee Robotics Ltd., Biosero Inc., Cognex Corp., Eppendorf SE, F. Hoffmann La Roche Ltd., Gilson Inc., LabVantage Solutions Inc., LabWare Inc., Olympus Corp., PerkinElmer Inc, QIAGEN NV, SCINOMIX, Siemens AG, SPT Labtech Ltd., Tecan Trading AG, and Thermo Fisher Scientific Inc.

Market Driver

The outsourcing of medical device manufacturing and drug discovery is a significant trend in the healthcare industry, driven by the need for US FDA-approved facilities, skilled labor at reasonable costs, and adherence to World Health Organization-Good Manufacturing Practice (WHO-GMP) standards. India is an attractive destination for healthcare contract research outsourcing due to its large number of US FDA-approved manufacturing plants, a talented workforce, and cost advantages. The implementation of product patents under the World Trade Organization Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement in 2005 further fueled outsourcing from developed markets. With the increasing demand for high-volume product orders, developing countries are investing in infrastructure and expertise, leading to the growth of the global laboratory automation systems market. The availability of efficient and cost-effective drug discovery in these countries is also contributing to market expansion during the forecast period. 

Laboratory automation systems are trending in the scientific community due to their ability to increase productivity, ensure safe working conditions, and provide reliable results in less time and effort. Integrated systems are becoming the norm, addressing issues like sample contamination and streamlining workflows. Automation dependence is growing, with robots restocking shelves and handling samples, while wireless connectivity enables seamless data transfer. High-throughput compound screening and fragment screening are key applications, with computer modeling and machine learning aiding potential therapeutic candidates’ discovery. FDA clearance is crucial for life-saving medical equipment, while precision medicine development relies on automated instruments for process automation. Sample handling, verifications, and labeling tubes are essential components, ensuring accurate results. Manufacturing machinery benefits from automation, reducing costs and improving efficiency. Immersive experiences and wireless connectivity enhance the user experience, making laboratory automation technology an indispensable tool for clinical laboratories. 

Discover 360° analysis of this market. For complete information, schedule your consultation – Book Here!

Market Challenges

Small- and medium-scale laboratories typically handle a lower volume of samples and focus on specific applications, such as diagnosis and testing of biological samples. Due to limited budgets, staff, and planning, automation is not a priority for these laboratories. Additionally, they often lack the necessary floor space for large-scale automation systems. In contrast, large-scale facilities can afford advanced automated solutions for processes like chemically relevant compound profiling, high-content screening, and large-scale cell culture development. However, small- and medium-scale laboratories are hesitant to invest in these technologically advanced products due to high maintenance and service costs related to laboratory informatics solutions. The lack of knowledge among professionals managing these laboratories regarding the benefits of automation further hinders adoption. These factors limit the growth of the global laboratory automation systems market during the forecast period.The Laboratory Automation Systems market is witnessing significant growth due to the increasing demand for automated solutions in various industries such as healthcare, food safety, and research. However, challenges persist in this market, including physical strain on lab personnel, miniaturization requirements in microbiology and biotechnology, and the need for accurate data analysis in clinical chemistry. To address these challenges, automated systems are being adopted for tasks like liquid handling, data management, and sample preparation. Government legislation, regulatory requirements, and budget constraints are also driving the market for automated systems. The total automation segment, including automated workstations and robotic systems, is experiencing high demand, especially in diagnostics, drug discovery, genomics, and proteomics. Customization services are essential to meet the unique needs of laboratories, whether high volume or specialized in forensics or healthcare applications. The market is expected to continue growing, offering benefits such as reduced repetitiveness, human intervention, time cycle, and improved data quality.

For more insights on driver and challenges – Request a sample report!

Segment Overview 

This laboratory automation systems market report extensively covers market segmentation by  

End-user 1.1 Pharmaceutical and biotechnology companies1.2 Clinical and reference laboratories1.3 Academic institutions and research organizations1.4 OthersType 2.1 Equipment2.2 Software2.3 servicesGeography 3.1 North America3.2 Europe3.3 Asia3.4 Rest of World (ROW)

1.1 Pharmaceutical and biotechnology companies-  Pharmaceutical and biotechnology companies are increasingly utilizing laboratory automation systems for high-content screening (HCS) applications in their drug discovery processes. Automated liquid handling systems are commonly used for screening clinically relevant compounds, isolating those with specific properties, and quantifying and analyzing screening assays. These systems can operate for extended periods with minimal supervision, enabling companies to focus on their core work and reduce time spent on repetitive tasks. Innovations like integrating analytical systems with software programs expedite the process and make it cost-effective. Longer runtimes and larger system sizes are further driving adoption. The emergence of new pharmaceutical and biotech firms focusing on novel drugs and molecular therapies is fueling market growth in this sector during the forecast period.

For more information on market segmentation with geographical analysis including forecast (2024-2028) and historic data (2017-2021) – Download a Sample Report

Research Analysis

Laboratory Automation Systems (LAS) are technological solutions designed to automate various laboratory processes, enhancing productivity, ensuring safe working conditions, and delivering reliable results. LAS encompasses automation of process steps such as sample handling, liquid handling, high throughput analysis, clinical chemistry analysis, and immunoassay analysis. These systems enable advanced data management, reduced human intervention, and total automation in segments like healthcare applications, clinical laboratories, diagnostic laboratories, and research institutions. Automated workstations and robotic systems are integral components of LAS, streamlining sample preparation and data analysis. LAS plays a pivotal role in improving laboratory efficiency, reducing errors, and ensuring consistent and accurate results.

Market Research Overview

Laboratory automation refers to the use of technology to automate various processes in laboratories, including the use of automated instruments for sample handling, verifications, labeling tubes, and data analysis. This technology offers numerous benefits, such as increased productivity, safe working conditions, reliable results, and reduced time and effort. Automated systems are used extensively in clinical laboratories, microbiology, biotechnology, clinical chemistry, and immunoassay analysis, among others. The market for laboratory automation systems is driven by the need for efficient and accurate laboratory processes, regulatory requirements, and government legislation. Automation enables reduction of repetitiveness and human intervention, resulting in enhanced workflow scope, reduced time cycle, and improved data quality. Automated liquid handlers, sample preparation, and data management are key components of laboratory automation systems. Miniaturization and immersive experience are emerging trends, with wireless connectivity and robots restocking shelves adding to the convenience. End users in the healthcare sector, including hospitals and diagnostic laboratories, are major consumers of laboratory automation systems. Budget constraints and emerging countries present opportunities for growth in the market. The diagnostics segment, including drug discovery, genomics solutions, proteomics solutions, and forensic laboratories, is a significant contributor to the market. Automated workstations, off-the-shelf automated workcells, and robotic systems are popular solutions. The total automation segment, with customization services, is gaining popularity due to the increasing complexity of laboratory needs. High volume laboratories, tables and accessories, and healthcare applications are other areas of focus. Laboratory automation systems offer significant benefits, including reduced repetitiveness, increased productivity, and improved data quality. However, challenges such as sample contamination, automation dependence, and FDA clearance must be addressed to ensure the success of these systems. Machine learning, InsilicoMedicine, and precision medicine development are emerging areas of application for laboratory automation systems. The potential therapeutic candidates identified through high-throughput compound screening and fragment screening offer significant opportunities for advancements in healthcare and manufacturing machinery.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

End-userPharmaceutical And Biotechnology CompaniesClinical And Reference LaboratoriesAcademic Institutions And Research OrganizationsOthersTypeEquipmentSoftwareServicesGeographyNorth AmericaEuropeAsiaRest Of World (ROW)

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/laboratory-automation-systems-market-size-is-set-to-grow-by-usd-2-01-billion-from-2024-2028–increasing-demand-for-laboratory-automation-software-services-boost-the-market-technavio-302210040.html

SOURCE Technavio

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Bloomberg Introduces Spread-to-Benchmark Quoting for EUR and GBP Portfolio Trading Baskets

Published

on

By

LONDON, June 2, 2026 /PRNewswire/ — Bloomberg today announced the launch of Spread-to-Benchmark quoting and trading for Euro (EUR) and Sterling (GBP) denominated portfolio trades through its Portfolio Trading Basket Builder (PTBB). The new functionality expands the range of quoting protocols available for European credit portfolio trading and reflects growing client demand for spread-based execution workflows, alongside increased dealer support for the convention across EUR and GBP markets.

Spread-to-Benchmark quoting is a well-established protocol for USD credit portfolio trades and is used by market participants to evaluate and execute portfolio trades. By extending this workflow to EUR and GBP portfolio trades, Bloomberg enables clients and dealers to transact using a familiar spread-based methodology across additional credit markets. 

The introduction of Spread-to-Benchmark quoting for EUR and GBP baskets reflects increased client interest in evaluating portfolio trades through a spread-based lens and the growing adoption of spread-based execution workflows in European credit markets. The workflow provides market participants with an additional framework for assessing the relationship between credit spread risk and underlying government bond yields when pricing and executing portfolio trades. 

Additional Workflow Flexibility 
The workflow complements Bloomberg’s existing portfolio trading capabilities, which support the full range of market-standard quoting conventions, including Price, Yield, Spread-to-Benchmark and Spread based workflows that reference Bloomberg’s evaluated pricing service (BVAL). This gives clients flexibility to compare and execute portfolio trades using the quoting methodology that best aligns with their investment objectives, execution preferences and internal risk management processes. 

“European credit clients continue to look for execution workflows that reflect how they evaluate risk and monitor portfolio trading outcomes,” said Harry Street, Global Head of Credit and Equities Trading Product at Bloomberg. “By expanding dealer support for Spread-to-Benchmark quoting for EUR and GBP baskets, Bloomberg is broadening the range of workflow options available to clients trading European credit portfolios.” 

“Portfolio trading workflows in fixed income continue to become more sophisticated as institutional investors look for ways to evaluate execution quality in changing market conditions,” said Kevin McPartland, Head of Market Structure & Technology Research at Crisil Coalition Greenwich. “Spread-based quoting helps market participants more clearly distinguish between the impacts of credit spread and underlying rates movements when determining how best to execute a portfolio trade.” 

Bloomberg’s Electronic Markets solutions are used by leading financial institutions to trade efficiently in over 175 markets around the world. More than 9,000 client firms use Bloomberg Electronic Markets to access industry-leading depth and breadth of liquidity across asset classes from over 800 dealers globally. Bloomberg Electronic Markets provides market participants with comprehensive solutions across the trading lifecycle, including robust price transparency, analytics, automation and execution, powered by Bloomberg’s high-quality, multi-asset class data and tools.

About Bloomberg
Bloomberg is a global leader in business and financial information, delivering trusted data, news, and insights that bring transparency, efficiency, and fairness to markets. The company helps connect influential communities across the global financial ecosystem via reliable technology solutions that enable our customers to make more informed decisions and foster better collaboration. For more information, visit Bloomberg.com/company or request a demo.

View original content to download multimedia:https://www.prnewswire.com/news-releases/bloomberg-introduces-spread-to-benchmark-quoting-for-eur-and-gbp-portfolio-trading-baskets-302787922.html

SOURCE Bloomberg L.P.

Continue Reading

Technology

Dr. Sunho Kang, a senior battery-technology executive with leadership experience at major global battery and EV manufacturers, joins TeraWatt Technology as Head of Product and Technology

Published

on

By

SAN FRANCISCO, June 2, 2026 /PRNewswire/ — TeraWatt Technology Inc. (Headquartered in California, USA) is pleased to announce that Dr. Sunho Kang has joined the company as Head of Product and Technology.

Dr. Kang is a globally recognized battery-technology executive with more than 25 years of leadership experience spanning the United States, Asia, and Europe, and a distinguished track record of advancing innovations from laboratory research through gigafactory-scale production. He has held senior executive positions at world-leading organizations including Samsung SDI, Apple, and Volkswagen Group of America, and brings deep expertise in lithium-ion battery materials, cell engineering, and product industrialization across a broad range of applications, including electric vehicles and energy storage systems.

At TeraWatt, Dr. Kang will lead global product development and the commercialization of TeraWatt’s battery technology platform, aiming to accelerate the delivery of TeraWatt’s competitive products as well as the technology and commercialization roadmap including manufacturing scale-up.

Dr. Kang commented:

“I am thrilled to join TeraWatt Technology as Head of Product and Technology. TeraWatt’s innovative battery platform presents a tremendous opportunity to push the boundaries of lithium-ion technology, and I look forward to working with the team to accelerate product development and commercialization to deliver meaningful impact.”

TeraWatt Technology founder CEO Ken Ogata, Ph.D. commented:

“We are thrilled to welcome Dr. Kang as our Head of Product and Technology. His deep expertise in battery materials, cell engineering, and productization will be instrumental in accelerating TeraWatt’s product roadmap and technology leadership. Together with Dr. Kang, we will continue to drive our mission forward.”

About TeraWatt Technology Inc.
TeraWatt Technology Inc. is a California-based company that produces lightweight, high-power, and safe next-generation lithium-ion batteries.

Company Overview
Name: TeraWatt Technology Inc.
Representative: Co-founder and CEO Ken Ogata
Headquarters: 28 Geary St, Suite 650, San Francisco, CA 94108, United States
Founded: January 2020
Established: December 2019
URL: https://www.terawatt-technology.com/

 

View original content:https://www.prnewswire.com/news-releases/dr-sunho-kang-a-senior-battery-technology-executive-with-leadership-experience-at-major-global-battery-and-ev-manufacturers-joins-terawatt-technology-as-head-of-product-and-technology-302786854.html

SOURCE TeraWatt Technology Inc.

Continue Reading

Technology

Tencent Cloud and Soniox Announce Strategic Partnership: Combining Advanced Speech-to-Text (STT) Technology with Global Real-Time Infrastructure

Published

on

By

HONG KONG, June 2, 2026 /PRNewswire/ — Tencent Cloud, the cloud business of global technology company Tencent, today announced a strategic partnership with Soniox, a San Francisco-based speech AI company that specializes in developing high-accuracy, low-latency speech AI solutions. The collaboration integrates Soniox’s speech-to-text (STT) technology with Tencent Cloud’s Real-Time Communication (TRTC) enterprise-grade global infrastructure, enabling enterprises to build and deploy multilingual voice AI applications across 200+ countries and regions.

Elevating Enterprise Voice AI at a Global Scale

In enterprise voice AI deployments, latency directly affects user experience and application reliability. The integration of Soniox’s high-accuracy, low-latency STT with TRTC’s global transmission infrastructure reduces latency across the entire pipeline, creating a comprehensive end-to-end solution for enterprises deploying conversational AI applications worldwide.    

Soniox is the voice platform for every language. Unlike legacy speech AI, which was built primarily for English-speakers, Soniox delivers native-speaker accuracy across 60+ languages. Its technology can handle mid-sentence language switching — a user can switch between English and Chinese in a single utterance, and Soniox will capture every word with complete accuracy. All of this works through a single API that works for both speech-to-text and text-to-speech.

By integrating TRTC, the partnership leverages an enterprise-grade real-time communication backbone featuring more than 3,200 global nodes, sub-300 ms worldwide latency, and advanced capabilities such as AI noise suppression and weak-network resilience. These capabilities enable conversational AI applications to operate reliably across diverse network environments, including regions such as Southeast Asia and Africa.

With the roll out of this partnership, developers can integrate the Soniox STT API directly within the Tencent Cloud console. Whether targeting English-speaking markets or supporting languages such as Arabic, Hindi, and Malay, enterprises can build global voice applications — including intelligent customer service, voice assistants, real-time translation, and meeting transcription — to address the demands of expansion into emerging markets and multilingual scenarios.

Wison Xie, Head of Product at Tencent RTC, stated: “Tencent RTC has always been committed to providing reliable real-time communication infrastructure for global enterprises. Our partnership with Soniox brings together our strengths in enterprise-grade audio transmission and Soniox’s advanced speech recognition technology. Together, we are making it easier for businesses to deploy accurate, low-latency voice AI applications across any language and any market.”

Klemen Simonic, CEO at Soniox Inc., stated “At Soniox, our mission is to help businesses understand every word, in any language, with native speaker accuracy and exceptional speed. Partnering with Tencent Cloud combines our speech AI with world-class real-time infrastructure, enabling enterprises to build voice AI experiences that scale globally with low latency and reliability.”

About Tencent Cloud:

Tencent Cloud, one of the world’s leading cloud companies, is committed to creating innovative solutions to resolve real-world issues and enabling digital transformation for smart industries. Through our extensive global infrastructure, Tencent Cloud provides businesses across the globe with stable and secure industry-leading cloud products and services, leveraging technological advancements such as cloud computing, Big Data analytics, AI, IoT, and network security. It is our constant mission to meet the needs of industries across the board, including the fields of gaming, media and entertainment, finance, healthcare, property, retail, travel, and transportation.

About Tencent RTC:

Tencent RTC provides real-time communication solutions, including audio/video calling, live streaming, and in-game voice. With enterprise-grade security, AI-powered enhancements, and a global network of over 3,200 nodes, Tencent RTC powers mission-critical communication for customers worldwide.

About Soniox:

Soniox is a next-generation voice AI company bringing about the end of English-first speech AI. Most people on the planet did not grow up speaking English and often mix languages mid-sentence; and yet legacy speech AI was built for just English. Soniox is different: native-speaker accuracy across 60+ languages, true mid-sentence language switching, and flawless alphanumeric recognition that legacy providers still can’t match. For developers building global apps, Soniox is the only option. Try it for yourself at soniox.com.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/tencent-cloud-and-soniox-announce-strategic-partnership-combining-advanced-speech-to-text-stt-technology-with-global-real-time-infrastructure-302786832.html

SOURCE Tencent Cloud

Continue Reading

Trending